Congressional spending plan: What’s in it for healthcare, and what isn’t
Chief Healthcare Executive December 21, 2024
Resilience Lab Expands Care Delivery for Treatment-Resistant Depression and Other Moderate and Severe Mental Illnesses with the Acquisition of Options MD
Healthcare IT Today November 15, 2024
Resilience Lab will Now Offer Medication Management in Addition to Therapy
Integrates a Proprietary AI-Powered Point-of-Care Decision Support Platform and Intake Process with Remission and Retention Rates Almost Double the Industry Standard
All Options MD Team Members will be Retained by Resilience Lab
Resilience Lab, a clinician-driven, AI-supported provider of high-quality care and mental health access, announced the acquisition of Options MD, a leader in high-quality online psychiatric medication management for severe and treatment-resistant depression (TRD). Severe and treatment-resistant depression is a serious and often overlooked mental health condition that contributes to high costs of care and high levels of patient disability. Resilience Lab will now offer integrated medication management and psychotherapy for moderate to severe mental illness...
Today's Sponsors
Today's Sponsor